Natera, Inc. — Director's Dealing 2021

Jun 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2021-06-14

Reporting Person: Chapman Steven Leonard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	M	26	$10.73	Acquired	78582	Direct
2021-06-14	Common Stock	M	2289	$9.29	Acquired	80871	Direct
2021-06-14	Common Stock	M	1563	$13.01	Acquired	82434	Direct
2021-06-14	Common Stock	M	7813	$13.01	Acquired	90247	Direct
2021-06-14	Common Stock	M	1563	$20.27	Acquired	91810	Direct
2021-06-14	Common Stock	M	4688	$25.46	Acquired	96498	Direct
2021-06-14	Common Stock	S	8846	$103.1450	Disposed	87652	Direct
2021-06-14	Common Stock	S	9096	$103.8305	Disposed	78556	Direct
2021-06-14	Common Stock	S	3041	$103.4056	Disposed	75515	Direct
2021-06-14	Common Stock	S	5109	$104.1452	Disposed	70406	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Stock Option (right to buy)	$10.73	M	26	Disposed	2027-07-13	Common Stock (26)	Direct
2021-06-14	Stock Option (right to buy)	$9.29	M	2289	Disposed	2028-03-08	Common Stock (2289)	Direct
2021-06-14	Stock Option (right to buy)	$13.01	M	1563	Disposed	2029-01-10	Common Stock (1563)	Direct
2021-06-14	Stock Option (right to buy)	$13.01	M	7813	Disposed	2029-01-10	Common Stock (7813)	Direct
2021-06-14	Stock Option (right to buy)	$20.27	M	1563	Disposed	2029-04-11	Common Stock (1563)	Direct
2021-06-14	Stock Option (right to buy)	$25.46	M	4688	Disposed	2030-03-26	Common Stock (4688)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021, as amended on May 14, 2021.

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.54 to $103.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.56 to $104.23 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.85 to $103.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.8450 to $104.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The option shares are fully vested and may be exercised at any time.

F7: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.

F8: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F9: This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to the remaining 31,250 shares

F10: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F11: The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.